AstraZeneca buys Spanish drug company's respiratory franchise for up to $2.1B By: Philadelphia Business Journal via Business Journals July 30, 2014 at 09:32 AM EDT AstraZeneca agreed on Wednesday to buy Almirall’s respiratory disorder treatment franchise in a deal valued at up to $2... Read More >> Related Stocks: Pfizer